General Information of This Antigen (ID: TAR0MIUKZ)
Antigen Name
Solute carrier family 3 member 2 (SLC3A2)
Gene Name
SLC3A2
Gene ID
6520
Synonym
MDU1; 4F2 heavy chain antigen;Lymphocyte activation antigen 4F2 large subunit;Solute carrier family 3 member 2;CD98
Sequence
MELQPPEASIAVVSIPRQLPGSHSEAGVQGLSAGDDSELGSHCVAQTGLELLASGDPLPS
ASQNAEMIETGSDCVTQAGLQLLASSDPPALASKNAEVTGTMSQDTEVDMKEVELNELEP
EKQPMNAASGAAMSLAGAEKNGLVKIKVAEDEAEAAAAAKFTGLSKEELLKVAGSPGWVR
TRWALLLLFWLGWLGMLAGAVVIIVRAPRCRELPAQKWWHTGALYRIGDLQAFQGHGAGN
LAGLKGRLDYLSSLKVKGLVLGPIHKNQKDDVAQTDLLQIDPNFGSKEDFDSLLQSAKKK
SIRVILDLTPNYRGENSWFSTQVDTVATKVKDALEFWLQAGVDGFQVRDIENLKDASSFL
AEWQNITKGFSEDRLLIAGTNSSDLQQILSLLESNKDLLLTSSYLSDSGSTGEHTKSLVT
QYLNATGNRWCSWSLSQARLLTSFLPAQLLRLYQLMLFTLPGTPVFSYGDEIGLDAAALP
GQPMEAPVMLWDESSFPDIPGAVSANMTVKGQSEDPGSLLSLFRRLSDQRSKERSLLHGD
FHAFSAGPGLFSYIRHWDQNERFLVVLNFGDVGLSAGLQASDLPASASLPAKADLLLSTQ
PGREEGSPLELERLKLEPHEGLLLRFPYAA

    Click to Show/Hide
Family
SLC34A transporter family
Function
Component of several heterodimeric complexes involved in amino acid transport. The precise substrate specificity depends on the other subunit in the heterodimer. The complexes function as amino acid exchangers. The heterodimer functions as sodium-independent, high-affinity transporter that mediates uptake of large neutral amino acids such as phenylalanine, tyrosine, leucine, histidine, methionine, tryptophan, valine and isoleucine. The heterodimer with SLC7A5/LAT1 mediates the uptake of L-DOPA. The heterodimer formed by SLC3A2 and SLC7A6 or SLC3A2 and SLC7A7 mediates the uptake of dibasic amino acids. The heterodimer with SLC7A5/LAT1 mediates the transport of thyroid hormones diiodothyronine (T2), triiodothyronine (T3) and thyroxine (T4) across the cell membrane. The heterodimer with SLC7A5/LAT1 is involved in the uptake of toxic methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes. When associated with LAPTM4B, the heterodimer with SLC7A5/LAT1 is recruited to lysosomes to promote leucine uptake into these organelles, and thereby mediates mTORC1 activation. The heterodimer with SLC7A5/LAT1 may play a role in the transport of L-DOPA across the blood-brain barrier. The heterodimer formed by SLC3A2 and SLC7A5/LAT1 or SLC3A2 and SLC7A8/LAT2 is involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L- nitrosocysteine (L-CNSO) across the transmembrane. The heterodimer with SLC7A10 translocates small neutral L- and D-amino acids across the plasma membrane. SLC3A2-SLC7A10 preferentially mediates exchange transport, but can also operate via facilitated diffusion. Together with ICAM1, regulates the transport activity of SLC7A8/LAT2 in polarized intestinal cells by generating and delivering intracellular signals. Required for .geting of SLC7A5/LAT1 and SLC7A8/LAT2 to the plasma membrane and for channel activity. Plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via transport of L-arginine. May mediate blood-to-retina L-leucine transport across the inner blood-retinal barrier.

    Click to Show/Hide
Uniprot Entry
4F2_HUMAN
HGNC ID
HGNC:11026
KEGG ID
hsa:6520
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
ADC Name Payload Target Linker ADC Info
38703658 19G4-MMAE [1]
Monomethyl auristatin E
Microtubule (MT)
Undisclosed
Anti-CD98- (MSG1-N3)2
ADC Name Payload Target Linker ADC Info
JP7615189B2 ADC51 [2]
JP7615189B2+ADC40+payload
Undisclosed
JP7615189B2+ADC41+Linker
JP7615189B2 ADC52 [2]
JP7615189B2+ADC38+payload
Undisclosed
JP7615189B2+ADC41+Linker
Undisclosed
ADC Name Payload Target Linker ADC Info
Anti-CD98 antibody-drug conjugate (Daiichi Sankyo) [3]
Undisclosed
Undisclosed
Undisclosed
EDC-3 [4]
Glycosylation scillarenin
Undisclosed
CEN010-105
CD98hc-ADC [5]
Mertansine DM1
Microtubule (MT)
Undisclosed
References
Ref 1 A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer
Ref 2 Antibody-pyrrolobenzodiazepine derivative conjugates
Ref 3 Introduction to basic information on ADC drug anti-CD98 antibody-drug conjugate (Daiichi Sankyo).
Ref 4 Introduction to basic information on ADC drug EDC-3
Ref 5 An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer